

We would like to thank Mustafa Turgut Yildizgören for his Correspondence, which gives us the opportunity to further clarify some of the rationale behind the design choices of the DISTRICTS study and its findings.1 The DISTRICTS trial compared the effectiveness of two treatment strategies for carpal tunnel syndrome: one starting with surgery and one starting with a corticosteroid injection, with the option to receive additional treatments in both strategies if needed.1 We deliberately chose not to impose a strict treatment protocol on participating centres.
General Medicine
|15th Jan, 2026
|The Lancet
General Medicine
|15th Jan, 2026
|The Lancet
General Medicine
|15th Jan, 2026
|The Lancet
General Medicine
|15th Jan, 2026
|The Lancet
General Medicine
|15th Jan, 2026
|The Lancet
General Medicine
|15th Jan, 2026
|The Lancet
General Medicine
|15th Jan, 2026
|The Lancet